Glepaglutide (ZP1848) acetate, a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide acetate reduces faecal output and increases intestinal absorption. Glepaglutide acetate alleviates small intestinal inflammation. Glepaglutide acetate can be used in the research of inflammatory bowel disease (IBD) and Crohn’s disease.
性状
Solid
IC50 & Target[1][2]
GLP-2R
体内研究(In Vivo)
Glepaglutide (ZP1848; 200 和 400 nmol/kg; 皮下注射; 每天两次; 持续 14 天) acetate 对小肠炎症大鼠显示出肠营养的作用。 has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Rats with Indomethacin (HY-1
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisture and light, under nitrogenPowder -80°C 2 years;-20°C 1 ye
[1]. Naimi RM, et al. a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2019 May;4(5):354-363. [2]. Janssen P, et al. Review article: a comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther. 2013 Jan;37(1):18-36.
溶解度数据
In Vitro: H2O : 100 mg/mL (22.85 mM; Need ultrasonic)配制储备液